Breaking News Instant updates and real-time market news.

PYPL

PayPal

$86.66

-0.37 (-0.43%)

, SQ

Square

$73.74

1.37 (1.89%)

10:04
08/14/18
08/14
10:04
08/14/18
10:04

Technical Take: Square hits new life high after positive Nomura note

As previously reported, Nomura put out a note saying that cumulative downloads of Square's Cash app surpassed PayPal's Venmo for the first time according to the firm's July data. Nomura raised its price target on Square (SQ) to $86. At the current price of $74.06, initial resistance is at the new high set today at $74.90. Thereafter there is no established resistance, opening up a run to the $77.50-$80 area. Support is at the current low of the day at $73.48.

PYPL

PayPal

$86.66

-0.37 (-0.43%)

SQ

Square

$73.74

1.37 (1.89%)

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 28

    Aug

  • 12

    Sep

PYPL PayPal
$86.66

-0.37 (-0.43%)

07/26/18
BARD
07/26/18
NO CHANGE
Target $96
BARD
Outperform
PayPal price target raised to $96 from $88 at Baird
Baird analyst Colin Sebastian raised his price target on PayPal to $96 from $88 following Q2 results. The analyst said the results are another validation of the company's "open platform" and consumer focused strategy to generate meaningful revenue and earnings growth. He also sees market shares gains in digital payments largely through M&A activity. Sebastian reiterated his Outperform rating on PayPal shares.
07/26/18
CHLM
07/26/18
NO CHANGE
Target $100
CHLM
Buy
PayPal price target raised to $100 from $93 at Craig-Hallum
Craig-Hallum analyst Bradley Berning raised his price target for PayPal to $100 from $93, while reiterating a Buy rating on the shares. While the stock was weak after hours on concerns over "quality of beat," the seasonally slower new account quarter, and dilution to 2019 from recent acquisitions, the analyst believes investors should use this opportunity to buy the stock.
07/27/18
RHCO
07/27/18
NO CHANGE
Target $240
RHCO
Buy
MasterCard price target raised to $240 from $215 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on MasterCard to $240 and kept his Buy rating, saying the company is demonstrating expansion of global market share while posting a 14% Q2 volume growth. The analyst adds that while MasterCard has a higher valuation than PayPal (PYPL) and Visa (V) - a 10% relative EBITDA premium - it is justified and may even be too narrow given its superior growth sustainability and margin upside.
08/14/18
NOMU
08/14/18
NO CHANGE
Target $86
NOMU
Buy
Square Cash App surpassed PayPal's Venmo for first time in July, says Nomura
Nomura Instinet analyst Dan Dolev raised his price target for Square (SQ) to $86 from $82 after his firm's July payments app tracker showed cumulative Square Cash App downloads surpassed PayPal's (PYPL) Venmo for the first time. Cash App downloads in July of 33.5M marked the highest monthly addition on record, Dolev tells investors in a research note. The analyst says the Square Cash App is growing three times faster than Venmo. He keeps a Buy rating on Square shares.
SQ Square
$73.74

1.37 (1.89%)

08/06/18
BUCK
08/06/18
UPGRADE
Target $42
BUCK
Buy
Square upgraded to Buy on revenue acceleration at Buckingham
As previously reported, Buckingham upgraded Square to Buy from Neutral and raised its price target to $85 from $65. Analyst Chris Brendler said the Q2 strong results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better-then-expected core revenue growth into 2020. Brendler said long-run adjusted EBITDA margins of 40-50% justify a higher valuation.
08/06/18
08/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Overweight from Neutral at Atlantic Equities with analyst Hamilton Faber saying he believes "the bulk of the M&A storm" has passed. 2. Qualcomm (QCOM) upgraded to Outperform from Market Perform at Cowen with analyst Matthew Ramsay citing the company's $30B buyback and saying he believes the shares offer a compelling risk/reward with effects of lower spending, solid customer performance, and potential QTL resolutions. 3. Square (SQ) upgraded to Buy from Neutral at Buckingham with analyst Chris Brendler saying the Q2 strong results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better-then-expected core revenue growth into 2020. 4. Parker-Hannifin (PH) upgraded to Outperform from In Line at Evercore ISI with analyst David Raso saying the company's recent operational struggles are behind it with this quarters report and views 2019 guidance as conservative. 5. Intercept (ICPT) upgraded to Buy from Sell at Goldman Sachs with analyst Salveen Richter saying Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/06/18
08/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. INTERCEPT DOUBLE UPGRADED AT GOLDMAN: Goldman Sachs analyst Salveen Richter double upgraded Intercept Pharmaceuticals (ICPT) to Buy from Sell and raised his price target for the shares to $157 from $46. The analyst said Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. Intercept should benefit from Ocaliva's global first-mover advantage in NASH, Richter said. In late morning trading, Intercept shares are up 12%. BUCKINGHAM UPGRADES SQUARE TO BUY: Buckingham upgraded Square (SQ) to Buy from Neutral and raised its price target to $85 from $65. Analyst Chris Brendler said the strong Q2 results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better then expected core revenue growth into 2020. Brendler said long-run adjusted EBITDA margins of 40%-50% justify a higher valuation. PIPER CUTS ACADIA TO NEUTRAL: Piper Jaffray analyst Danielle Brill downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Overweight and cut her firm's price target on shares to $19 from $61 after taking over coverage of the name. The recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future, Brill said. Further, the analyst does not have a high level of conviction for positive data from Acadia's near-term catalysts, namely the Phase 2 major depressive disorder data in September and the Phase 2 negative schizophrenia symptoms readout in the first half of 2019. BARCLAYS CUTS INTEL TO EQUAL WEIGHT: Barclays analyst Blayne Curtis downgraded Intel (INTC) to Equal Weight from Overweight and cut his price target for the shares to $53 from $62. The analyst believes upside in the shares will be challenging until the company's margins bottom. JEFFERIES SAYS OHIO INCIDENT NOT A RISK TO CHIPOTLE TRAFFIC: After analyzing digital engagement with the brand from last week and compared to the Virginia incident last July, Jefferies analyst Andy Barish does not believe the illnesses at the Ohio restaurant put Chipotle Mexican Grill's (CMG) traffic trends at risk. The analyst believes Chipotle's procedures were followed in Ohio, the number of cases was not substantiated, and the company did a better job controlling the narrative and taking action. Barish kept a Buy rating on Chipotle shares with a $550 price target.

TODAY'S FREE FLY STORIES

XLNX

Xilinx

$119.20

-0.83 (-0.69%)

09:14
02/22/19
02/22
09:14
02/22/19
09:14
Recommendations
Xilinx analyst commentary  »

Xilinx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

FSLR

First Solar

$51.91

0.23 (0.45%)

09:13
02/22/19
02/22
09:13
02/22/19
09:13
Recommendations
First Solar analyst commentary  »

First Solar remains top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$21.70

3.44 (18.84%)

09:12
02/22/19
02/22
09:12
02/22/19
09:12
Recommendations
Delphi Technologies analyst commentary  »

Delphi Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$37.81

0.15 (0.40%)

09:11
02/22/19
02/22
09:11
02/22/19
09:11
Recommendations
Fluor analyst commentary  »

Fluor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:10
02/22/19
02/22
09:10
02/22/19
09:10
General news
Fedspeak highlights with several policymakers at a monetary policy forum toda »

Fedspeak highlights with…

PAAS

Pan American Silver

$14.17

-0.51 (-3.47%)

, TAHO

Tahoe Resources

$3.67

-0.12 (-3.17%)

09:09
02/22/19
02/22
09:09
02/22/19
09:09
Hot Stocks
Pan American Silver completes acquisition of Tahoe Resources »

Pan American Silver…

PAAS

Pan American Silver

$14.17

-0.51 (-3.47%)

TAHO

Tahoe Resources

$3.67

-0.12 (-3.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

, STMP

Stamps.com

$198.08

-4.03 (-1.99%)

09:09
02/22/19
02/22
09:09
02/22/19
09:09
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Newmont Mining…

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

STMP

Stamps.com

$198.08

-4.03 (-1.99%)

NEM

Newmont Mining

$35.39

0.02 (0.06%)

GOLD

Barrick Gold

$13.31

-0.46 (-3.34%)

ACHV

Achieve Life Sciences

$1.80

0.195 (12.15%)

INTC

Intel

$51.40

-0.01 (-0.02%)

W

Wayfair

$117.14

-0.87 (-0.74%)

TTD

Trade Desk

$150.18

0.07 (0.05%)

AN

AutoNation

$38.37

-0.76 (-1.94%)

FIT

Fitbit

$6.62

-0.03 (-0.45%)

LRCX

Lam Research

$178.83

-3.28 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 27

    Feb

  • 03

    Mar

  • 06

    Mar

  • 06

    Mar

  • 25

    Mar

  • 26

    Mar

DSX

Diana Shipping

$3.03

0.03 (1.00%)

09:08
02/22/19
02/22
09:08
02/22/19
09:08
Hot Stocks
Diana Shipping announces time charter contract with Koch for m/v Houston »

Diana Shipping announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$21.70

3.44 (18.84%)

09:07
02/22/19
02/22
09:07
02/22/19
09:07
Recommendations
Delphi Technologies analyst commentary  »

Delphi Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VKTX

Viking Therapeutics

$8.62

-0.15 (-1.71%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Initiation
Viking Therapeutics initiated  »

Viking Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$41.52

-0.7 (-1.66%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Periodicals
U.S China trade negotators seek resolution of Micron-Fujian Jinhua spat, FT says »

U.S. and Chinese trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    May

XOM

Exxon Mobil

$77.84

-0.7 (-0.89%)

, MSFT

Microsoft

$109.47

2.27 (2.12%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Hot Stocks
Exxon Mobil partners with Microsoft to increase Permian profitability »

ExxonMobil (XOM) said a…

XOM

Exxon Mobil

$77.84

-0.7 (-0.89%)

MSFT

Microsoft

$109.47

2.27 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 01

    Mar

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 18

    Mar

EQ

Equillium

$5.76

-0.56 (-8.86%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Initiation
Equillium initiated  »

Equillium initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$18.13

-0.99 (-5.18%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Hot Stocks
Yext doubles workforce in France, names Selwa Hussain as EMEA CFO »

Yext announced the growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

ORTX

Orchard Therapeutics

$16.00

(0.00%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Hot Stocks
Orchard Therapeutics presents follow-up data from OTL-101 trial »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRVB

Provention Bio

$2.42

0.09 (3.86%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Initiation
Provention Bio initiated  »

Provention Bio initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNKD

MannKind

$1.45

-0.025 (-1.70%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Initiation
MannKind initiated  »

MannKind initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

DERM

Dermira

09:03
02/22/19
02/22
09:03
02/22/19
09:03
Initiation
Dermira initiated  »

Dermira initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MDGL

Madrigal Pharmaceuticals

$125.62

2.5 (2.03%)

09:03
02/22/19
02/22
09:03
02/22/19
09:03
Initiation
Madrigal Pharmaceuticals initiated  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 19

    Mar

ICPT

Intercept

$91.83

-7.17 (-7.24%)

09:03
02/22/19
02/22
09:03
02/22/19
09:03
Initiation
Intercept initiated  »

Intercept initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

NTRA

Natera

$16.00

-0.17 (-1.05%)

09:02
02/22/19
02/22
09:02
02/22/19
09:02
Hot Stocks
Natera's dd-cfDNA test shows 'superior performance' in study »

Natera announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$1.28

0.08 (6.67%)

09:02
02/22/19
02/22
09:02
02/22/19
09:02
Syndicate
Trillium Therapeutics 18.75M share Spot Secondary priced at 80c »

Cowen acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ROKU

Roku

$51.47

-2.16 (-4.03%)

09:01
02/22/19
02/22
09:01
02/22/19
09:01
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$38.37

-0.76 (-1.94%)

, TSLA

Tesla

$291.18

-11.33 (-3.75%)

09:01
02/22/19
02/22
09:01
02/22/19
09:01
Periodicals
AutoNation CEO says Elon Musk acts in 'almost unethical way', CNBC reports »

AutoNation (AN) outgoing…

AN

AutoNation

$38.37

-0.76 (-1.94%)

TSLA

Tesla

$291.18

-11.33 (-3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 27

    Feb

  • 18

    Mar

  • 19

    Mar

GLPG

Galapagos NV

$97.83

-3.2 (-3.17%)

09:00
02/22/19
02/22
09:00
02/22/19
09:00
Initiation
Galapagos NV initiated  »

Galapagos NV initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.